- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Lexaria Bioscience Corp (LEXX)
Lexaria Bioscience Corp stock price live, this page displays NASDAQ LEXX stock exchange data. View the LEXX premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Lexaria Bioscience Corp real time stock price chart below.
What Is the Lexaria Bioscience Corp Stock Price Today?
The Lexaria Bioscience Corp stock price today is 1.060.
What Is the Stock Symbol for Lexaria Bioscience Corp?
The stock symbol for Lexaria Bioscience Corp is ""LEXX.""
What Stock Exchange Does Lexaria Bioscience Corp Trade On?
Lexaria Bioscience Corp is listed and trades on the NASDAQ stock exchange.
Is Lexaria Bioscience Corp a Good Stock to Buy?
Determining whether Lexaria Bioscience Corp—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the LEXX quote. (ISIN: US52886N4060)
What Is the Lexaria Bioscience Corp Stock Price Today?
The Lexaria Bioscience Corp stock price today is 1.060.
What Is the Stock Symbol for Lexaria Bioscience Corp?
The stock symbol for Lexaria Bioscience Corp is ""LEXX.""
What Stock Exchange Does Lexaria Bioscience Corp Trade On?
Lexaria Bioscience Corp is listed and trades on the NASDAQ stock exchange.
Is Lexaria Bioscience Corp a Good Stock to Buy?
Determining whether Lexaria Bioscience Corp—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the LEXX quote. (ISIN: US52886N4060)
NASDAQ
Currency in USD
Fair Value
An estimate of a Lexaria Bioscience's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.000
1.100
52 wk Range
0.775
2.850
LEXX is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Lexaria Bioscience's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.0001.100
52 wk Range
0.7752.850
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
LEXX Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Lexaria Bioscience's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceAnalysts Sentiment
Strong Buy
Price Target
5.333
Upside
+403.14%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Net income is expected to grow this year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Neutral
Lexaria Bioscience Corp Company Profile
Lexaria Bioscience Corp. operates as a biotechnology company. The company offers its patented drug delivery-enabling platform technology, DehydraTECH, which combines active pharmaceutical ingredients (APIs) with specific long-chain fatty acid-rich triglyceride oils and carrier compounds that improve the way they enter the bloodstream, increasing their effectiveness and allowing for lower overall dosing for improved tolerability while promoting healthier oral ingestion methods. Its DehydraTECH is used with a range of active molecules, including glucagon-like peptide-1 drugs (GLP-1) and glucose -dependent insulinotropic polypeptide drugs (GIP), vitamins, pain medications, hormones, phosphodiesterase type 5 (PDE5) inhibitors, antivirals, nicotine and its analogs, and cannabinoids. The company’s DehydraTECH technology is applied to various therapeutic indications, such as diabetes, weight loss, hypertension, epilepsy, and heart disease; is implemented in a multitude of ingestible or topically administered product formats comprising oral suspensions, tablets, capsules, foods, beverages, and oral products; and is suitable for a variety of product formats, including pharmaceuticals, nutraceuticals, over-the-counter products, and consumer packaged goods. The company was formerly known as Lexaria Corp. and changed its name to Lexaria Bioscience Corp. in April 2016. Lexaria Bioscience Corp. was incorporated in 2004 and is headquartered in Kelowna, Canada.
Compare LEXX to Peers and Sector
Metrics to compare | LEXX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipLEXXPeersSector | |
|---|---|---|---|---|
P/E Ratio | −2.0x | −0.4x | −0.6x | |
PEG Ratio | 0.05 | 0.00 | 0.00 | |
Price/Book | 7.9x | 0.2x | 2.6x | |
Price / LTM Sales | 33.4x | 1.2x | 3.3x | |
Upside (Analyst Target) | - | 3.9% | 41.8% | |
Fair Value Upside | Unlock | 1.7% | 6.2% | Unlock |
Analyst Ratings
2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 5.333
(+403.14% Upside)
Earnings
Latest Release
Oct 29, 2025
EPS / Forecast
-0.14 / -0.155
Revenue / Forecast
174.00K / 137.00K
People Also Watch
FAQ
What Stock Exchange Does Lexaria Bioscience Trade On?
Lexaria Bioscience is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for Lexaria Bioscience?
The stock symbol for Lexaria Bioscience is "LEXX."
What Is the Lexaria Bioscience Market Cap?
As of today, Lexaria Bioscience market cap is 23.56M.
What Is Lexaria Bioscience's Earnings Per Share (TTM)?
The Lexaria Bioscience EPS (TTM) is -0.66.
When Is the Next Lexaria Bioscience Earnings Date?
Lexaria Bioscience will release its next earnings report on 20 Jan 2026.
From a Technical Analysis Perspective, Is LEXX a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.
How Many Times Has Lexaria Bioscience Stock Split?
Lexaria Bioscience has split 3 times.
How Many Employees Does Lexaria Bioscience Have?
Lexaria Bioscience has 7 employees.
What is the current trading status of Lexaria Bioscience (LEXX)?
As of 03 Dec 2025, Lexaria Bioscience (LEXX) is trading at a price of 1.060, with a previous close of 1.060. The stock has fluctuated within a day range of 1.000 to 1.100, while its 52-week range spans from 0.775 to 2.850.
What Is Lexaria Bioscience (LEXX) Price Target According to Analysts?
The average 12-month price target for Lexaria Bioscience is USD5.33333, with a high estimate of USD6 and a low estimate of USD4. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +403.14% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.